133 related articles for article (PubMed ID: 3753519)
1. Elevated choline levels in brain. A non-cholinergic component of organophosphate toxicity.
Flynn CJ; Wecker L
Biochem Pharmacol; 1986 Sep; 35(18):3115-21. PubMed ID: 3753519
[TBL] [Abstract][Full Text] [Related]
2. Effects of soman and sarin on high affinity choline uptake by rat brain synaptosomes.
Whalley CE; Shih TM
Brain Res Bull; 1989 May; 22(5):853-8. PubMed ID: 2765946
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of locomotor depression and ChE activity after DFP, soman and sarin.
Lynch MR; Rice MA; Robinson SE
Pharmacol Biochem Behav; 1986 Apr; 24(4):941-7. PubMed ID: 3714785
[TBL] [Abstract][Full Text] [Related]
4. An assessment of comparative acute toxicity of diisopropyl-fluorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats.
Sivam SP; Hoskins B; Ho IK
Fundam Appl Toxicol; 1984 Aug; 4(4):531-8. PubMed ID: 6479498
[TBL] [Abstract][Full Text] [Related]
5. Studies on low dose sub-acute administration of soman, sarin and tabun in the rat.
Dulaney MD; Hoskins B; Ho IK
Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):234-41. PubMed ID: 4083033
[TBL] [Abstract][Full Text] [Related]
6. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.
Clement JG
Biochem Pharmacol; 1982 Apr; 31(7):1283-7. PubMed ID: 7092921
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic systems influence local cerebral glucose use in specific anatomical areas: diisopropyl phosphorofluoridate versus soman.
Churchill L; Pazdernik TL; Cross RS; Giesler MP; Nelson SR; Samson FE
Neuroscience; 1987 Jan; 20(1):329-39. PubMed ID: 3561766
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic actions of diazepam and atropine sulfate in soman poisoning.
Shih TM
Brain Res Bull; 1991 Apr; 26(4):565-73. PubMed ID: 1868356
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice.
Tripathi HL; Dewey WL
J Toxicol Environ Health; 1989; 26(4):437-46. PubMed ID: 2709438
[TBL] [Abstract][Full Text] [Related]
10. Effects of diisopropyl phosphofluoridate, sarin and soman on the accessibility of proteins, in the electroplax membrane, to lactoperoxidase-catalyzed iodination.
Schupper H; Rosenberg P
Biochem Pharmacol; 1991 Sep; 42(7):1463-73. PubMed ID: 1930270
[TBL] [Abstract][Full Text] [Related]
11. Organophosphorus anticholinesterases do not mediate analgesia through inhibition of enkephalin degradation.
Marchner H; Haraldsson S; Lundberg S
Life Sci; 1986 Apr; 38(14):1317-21. PubMed ID: 3515093
[TBL] [Abstract][Full Text] [Related]
12. Potential of memantine, D-tubocurarine, and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX.
Gupta RC; Dettbarn WD
Neurotoxicology; 1992; 13(3):649-61. PubMed ID: 1475066
[TBL] [Abstract][Full Text] [Related]
13. Effects of organophosphates on presynaptic events in the vascularly perfused phrenic nerve-hemidiaphragm preparation from the rat.
Andersen RA; Malthe-Sørenssen D; Odden E; Fonnum F
Biochem Pharmacol; 1987 Apr; 36(7):1107-17. PubMed ID: 3566805
[TBL] [Abstract][Full Text] [Related]
14. Soman and sarin induce a long-lasting naloxone-reversible analgesia in mice.
Clement JG; Copeman HT
Life Sci; 1984 Apr; 34(15):1415-22. PubMed ID: 6708739
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the neurotoxicities of Soman, Sarin and Tabun, and acetylcholinesterase inhibition.
Hoskins B; Fernando JC; Dulaney MD; Lim DK; Liu DD; Watanabe HK; Ho IK
Toxicol Lett; 1986 Feb; 30(2):121-9. PubMed ID: 3705100
[TBL] [Abstract][Full Text] [Related]
16. Concomitant increases in the levels of choline and free fatty acids in rat brain: evidence supporting the seizure-induced hydrolysis of phosphatidylcholine.
Flynn CJ; Wecker L
J Neurochem; 1987 Apr; 48(4):1178-84. PubMed ID: 3819725
[TBL] [Abstract][Full Text] [Related]
17. Variability of neurotoxicity of and lack of tolerance to the anticholinesterases soman and sarin in the rat.
Fernando JC; Lim DK; Hoskins B; Ho IK
Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):415-30. PubMed ID: 4023423
[TBL] [Abstract][Full Text] [Related]
18. Acute behavioural effects of the organophosphates sarin and soman in rats.
Nieminen SA; Lecklin A; Heikkinen O; Ylitalo P
Pharmacol Toxicol; 1990 Jul; 67(1):36-40. PubMed ID: 2395814
[TBL] [Abstract][Full Text] [Related]
19. Cerebral acetylcholine and choline contents and turnover following low-dose acetylcholinesterase inhibitors treatment in rats.
Shih TM; Scremin OU; Roch M; Huynh L; Sun W; Jenden DJ
Arch Toxicol; 2006 Nov; 80(11):761-7. PubMed ID: 16628397
[TBL] [Abstract][Full Text] [Related]
20. Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase.
Misulis KE; Clinton ME; Dettbarn WD; Gupta RC
Toxicol Appl Pharmacol; 1987 Jul; 89(3):391-8. PubMed ID: 3603567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
